Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-Guerin.
作者信息
Thatcher N, Blackledge G, Palmer M K, Crowther D
出版信息
Eur J Cancer (1965). 1981 Apr;17(4):465-9. doi: 10.1016/0014-2964(81)90256-5.
PMID:7308256
Abstract
摘要
相似文献
1
Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-Guerin.使用长春新碱（NSC-67574）、达卡巴嗪（NSC-45388）和卡介苗对转移性恶性黑色素瘤进行化学免疫疗法。
Eur J Cancer (1965). 1981 Apr;17(4):465-9. doi: 10.1016/0014-2964(81)90256-5.
2
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.卡介苗免疫疗法联合达卡巴嗪（NSC-45388）治疗恶性黑色素瘤。
Cancer Treat Rep. 1976 Feb;60(2):177-82.
3
[Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].氮烯咪胺与卡介苗辅助化学免疫疗法治疗恶性黑色素瘤的经验（作者译）
Z Hautkr. 1982 Feb 15;57(4):294-7.
4
Adjuvant treatment in stage I and II malignant melanoma: a randomized trial between chemoimmunotherapy and immunotherapy.I期和II期恶性黑色素瘤的辅助治疗：化学免疫疗法与免疫疗法的随机试验。
Dermatologica. 1991;183(1):25-30. doi: 10.1159/000247627.
5
Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.“高危”原发性恶性黑色素瘤辅助治疗的随机试验
Surgery. 1978 Jun;83(6):677-81.
6
A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
Cancer. 1985 Feb 15;55(4):707-12. doi: 10.1002/1097-0142(19850215)55:4<707::aid-cncr2820550406>3.0.co;2-5.
7
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.用二甲基三氮烯咪唑甲酰胺和卡介苗对播散性恶性黑色素瘤进行化学免疫治疗。
N Engl J Med. 1974 Sep 19;291(12):592-7. doi: 10.1056/NEJM197409192911202.
8
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).达卡巴嗪（NSC - 45388）与黑色素瘤联合治疗。I. 达卡巴嗪、卡莫司汀（NSC - 409962）、洛莫司汀（NSC - 79037）、长春新碱（NSC - 67574）及羟基脲（NSC - 32065）的研究
Cancer Treat Rep. 1976 May;60(5):601-9.
9
10
Results of a nonrandomized trial in malignant melanoma patients (Clark's stages III--V) treated by post-surgical chemoimmunotherapy.一项针对接受术后化学免疫疗法治疗的恶性黑色素瘤患者（克拉克分期III - V期）的非随机试验结果。
Recent Results Cancer Res. 1978;68:363-6. doi: 10.1007/978-3-642-81332-0_54.
Zotero 插件